Preventing the common cold with a garlic supplement: A double-blind, placebo-controlled survey
- 784 Downloads
One hundred forty-six volunteers were randomized to receive a placebo or an allicin-containing garlic supplement, one capsule daily, over a 12-week period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. The active-treatment group had significantly fewer colds than the placebo group (24 vs 65,P < .001). The placebo group, in contrast, recorded significantly more days challenged virally (366 vs 111,P < .05) and a significantly longer duration of symptoms (5.01 vs 1.52 days,P < .001). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Volunteers taking placebo were much more likely to get more than one cold over the treatment period. An allicin-containing supplement can prevent attack by the common cold virus.
Keywordsallicin common cold garlic supplement
Unable to display preview. Download preview PDF.
- 1.Eccles R. Common Cold Centre, Cardiff, UK. Available at: http://www.cf.ac.uk/biosi/ associates/cold/home.html.Google Scholar
- 2.Koch HP, Lawson LD.Garlic—The Science and Therapeutic Application of Allium Sativum L and Related Species. Baltimore: Williams & Wilkins; 1996.Google Scholar
- 4.Hanley AB, Fenwick CR. Cultivated alliums.J Plant Foods. 1985;6:211–238.Google Scholar
- 5.Data on file. Garlic Centre, East Sussex, UK.Google Scholar